7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2022-12-31 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-09-30 2019-09-30 2019-06-30 2019-03-31 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2013-03-31 2012-03-31 2010-09-30 
      
    		                          
      cash flows from operating activities
    		                          
      net income
    		183,000,000 414,000,000 177,000,000 214,000,000 190,000,000 307,000,000 113,000,000 230,000,000 190,000,000 273,000,000 134,000,000 207,000,000 19,000,000 -1,840,000,000 281,000,000 475,000,000 441,000,000 466,000,000 515,000,000 452,000,000 355,000,000 292,000,000 403,000,000 413,000 545,000,000 253,000 
      adjustments to reconcile net income to net cash from operating activities
    		                          
      depreciation
    		324,000,000 322,000,000 322,000,000 322,000,000 319,000,000 316,000,000 314,000,000 314,000,000 309,000,000 271,000,000 272,000,000 274,000,000 269,000,000 267,000,000 323,000,000 306,000,000 300,000,000 284,000,000 273,000,000 269,000,000 257,000,000 246,000,000 242,000,000   129,000 
      amortization
    		29,000,000 20,000,000 17,000,000 14,000,000 23,000,000 24,000,000 20,000,000 22,000,000 22,000,000 7,000,000 9,000,000 -10,000,000 29,000,000 11,000,000 18,000,000 29,000,000 9,000,000 22,000,000 13,000,000 21,000,000 27,000,000 22,000,000 23,000,000   87,000 
      defined benefit plans - income
    		-14,000,000 -16,000,000  -17,000,000 -20,000,000 -15,000,000  -19,000,000      4,000,000 -50,000,000            
      deferred income taxes and investment tax credits
    		66,000,000 38,000,000 49,000,000 33,000,000 42,000,000 72,000,000 180,000,000 35,000,000 124,000,000 39,000,000 36,000,000 22,000,000 -21,000,000 50,000,000 186,000,000 103,000,000 65,000,000 89,000,000 112,000,000 59,000,000 83,000,000 40,000,000 161,000,000   -116,000 
      other
    		-10,000,000 13,000,000 -30,000,000 3,000,000 7,000,000 3,000,000 -6,000,000 -48,000,000 3,000,000 -4,000,000 13,000,000 16,000,000 -4,000,000 -5,000,000 -8,000,000 -8,000,000 -4,000,000 -3,000,000 -6,000,000 -3,000,000 -3,000,000 -4,000,000 -1,000,000   -5,000 
      change in current assets and current liabilities
    		                          
      accounts receivable
    		186,000,000 -277,000,000 -5,000,000 97,000,000 237,000,000 -75,000,000 -133,000,000 -36,000,000 -73,000,000 -38,000,000    -60,000,000 -50,000,000 35,000,000 79,000,000 -57,000,000 117,000,000 -71,000,000 -1,000,000 69,000,000 -43,000,000   -48,000 
      accounts payable
    		-47,000,000 -120,000,000 195,000,000 -69,000,000 54,000,000 -221,000,000 57,000,000 80,000,000 238,000,000 4,000,000 56,000,000 -6,000,000 16,000,000 -42,000,000 63,000,000 -14,000,000 -8,000,000 -94,000,000 -54,000,000 -36,000,000 -1,000,000 -8,000,000 -84,000,000   -5,000 
      unbilled revenues
    		-45,000,000 108,000,000 -166,000,000 35,000,000 17,000,000 57,000,000 -96,000,000 -9,000,000 -239,000,000 28,000,000  14,000,000 -23,000,000 76,000,000 19,000,000 -12,000,000 22,000,000 48,000,000 33,000,000 58,000,000 11,000,000 18,000,000 52,000,000    
      fuel, materials and supplies
    		-24,000,000 37,000,000 7,000,000 -13,000,000 -29,000,000 33,000,000 -17,000,000 -13,000,000 -19,000,000 42,000,000    41,000,000 -14,000,000 -10,000,000 -12,000,000 31,000,000 -11,000,000 43,000,000 -7,000,000 -2,000,000 44,000,000    
      prepayments
    		31,000,000 -87,000,000 41,000,000 32,000,000 1,000,000 -108,000,000  46,000,000  -75,000,000  29,000,000 14,000,000 -76,000,000 22,000,000 26,000,000 7,000,000 -86,000,000 13,000,000 -73,000,000 29,000,000 44,000,000 -110,000,000   108,000 
      taxes payable
    		0 40,000,000 -19,000,000 13,000,000 26,000,000 -47,000,000 21,000,000 16,000,000 -66,000,000 -4,000,000 -48,000,000 -117,000,000       6,000,000 22,000,000 33,000,000 -6,000,000 -21,000,000    
      regulatory assets and liabilities
    		-15,000,000 79,000,000 -14,000,000 20,000,000 -13,000,000 -61,000,000 -10,000,000 30,000,000 39,000,000 -41,000,000 2,000,000 11,000,000 10,000,000 29,000,000 3,000,000 10,000,000 -47,000,000 -25,000,000 -22,000,000 64,000,000       
      accrued interest
    		-72,000,000 67,000,000 -71,000,000 83,000,000 -69,000,000 90,000,000 -96,000,000 79,000,000  57,000,000    69,000,000 141,000,000 137,000,000 -111,000,000 48,000,000   126,000,000      
      other operating activities
    		                          
      defined benefit plans - funding
    		-2,000,000 -5,000,000 0 -3,000,000 -2,000,000 -5,000,000 1,000,000 -7,000,000 -4,000,000 -3,000,000 -12,000,000 -5,000,000 -3,000,000 -33,000,000 -71,000,000 -74,000,000 -80,000,000 -127,000,000 -56,000,000 -150,000,000 -6,000,000 -32,000,000 -520,000,000   -26,000 
      other assets
    		-27,000,000 -50,000,000 -30,000,000 -6,000,000 -59,000,000 -1,000,000 -11,000,000 39,000,000 -49,000,000 -18,000,000 -6,000,000 -35,000,000 4,000,000 -74,000,000 -34,000,000 -35,000,000 31,000,000 -20,000,000 -37,000,000 -30,000,000 5,000,000 -6,000,000 5,000,000   -58,000 
      other liabilities
    		11,000,000 10,000,000 -14,000,000 44,000,000 -4,000,000 16,000,000 -305,000,000 -23,000,000 -31,000,000 6,000,000 -11,000,000 -5,000,000 -7,000,000 31,000,000 6,000,000 -26,000,000 -20,000,000 -10,000,000 69,000,000 -12,000,000 6,000,000 -15,000,000 4,000,000   0 
      net cash from operating activities
    		602,000,000 513,000,000 511,000,000 781,000,000 766,000,000 282,000,000 110,000,000 806,000,000 219,000,000 502,000,000 292,000,000 457,000,000 858,000,000 663,000,000 948,000,000 818,000,000 596,000,000 474,000,000 759,000,000 566,000,000 964,000,000 655,000,000 135,000,000   1,124,000 
      capex
    		-930,000,000 -396,000,000 -860,000,000 -679,000,000 -670,000,000 -343,000,000 -649,000,000 -651,000,000 -640,000,000 -191,000,000 -513,000,000 -491,000,000 -498,000,000 -242,000,000 -772,000,000 -723,000,000 -745,000,000 -407,000,000 -777,000,000 -437,000,000 -779,000,000 -696,000,000 -441,000,000   -356,000 
      free cash flows
    		-328,000,000 117,000,000 -349,000,000 102,000,000 96,000,000 -61,000,000 -539,000,000 155,000,000 -421,000,000 311,000,000 -221,000,000 -34,000,000 360,000,000 421,000,000 176,000,000 95,000,000 -149,000,000 67,000,000 -18,000,000 129,000,000 185,000,000 -41,000,000 -306,000,000   768,000 
      cash flows from investing activities
    		                          
      expenditures for property, plant and equipment
    		-930,000,000 -793,000,000 -860,000,000 -679,000,000 -670,000,000 -596,000,000 -649,000,000 -651,000,000 -640,000,000 -427,000,000 -513,000,000 -491,000,000 -498,000,000 -471,000,000 -772,000,000 -723,000,000 -745,000,000 -729,000,000 -777,000,000 -750,000,000 -779,000,000 -696,000,000 -677,000,000 -828,000 -682,000,000 -356,000 
      other investing activities
    		0 10,000,000 -14,000,000 -4,000,000 0 5,000,000 5,000,000 8,000,000 12,000,000  -1,000,000 -14,000,000 -7,000,000 -1,000,000 -6,000,000 6,000,000 -16,000,000 5,000,000 -61,000,000 4,000,000 7,000,000 5,000,000 1,000,000 -15,000 -19,000,000 1,000 
      net cash from investing activities
    		-930,000,000 -783,000,000 -874,000,000 -683,000,000 -670,000,000 -591,000,000 -644,000,000 -643,000,000 -468,000,000 -427,000,000 -514,000,000 -505,000,000 9,711,000,000 -735,000,000 -785,000,000 -715,000,000 -757,000,000 -722,000,000 -896,000,000 -753,000,000 -782,000,000 -705,000,000 -677,000,000   -382,000 
      cash flows from financing activities
    		                          
      issuance of long-term debt
    		  0 746,000,000 0 1,148,000,000 125,000,000 0 0  0 0   0 696,000,000   440,000,000 144,000,000 494,000,000 530,000,000 64,000,000 450,000  3,000 
      payment of common stock dividends
    		-202,000,000 -190,000,000 -190,000,000 -190,000,000 -190,000,000 -177,000,000 -178,000,000 -178,000,000 -167,000,000 -306,000,000 -318,000,000 -321,000,000 -320,000,000 -320,000,000 -320,000,000 -299,000,000 -298,000,000 -296,000,000 -285,000,000 -273,000,000 -271,000,000 -271,000,000 -258,000,000 -210,000 -203,000,000 -134,000 
      net increase in short-term debt
    		508,000,000 475,000,000    -701,000,000 705,000,000 44,000,000 475,000,000 916,000,000 69,000,000 0 -1,547,000,000 752,000,000 525,000,000 -240,000,000 -218,000,000 424,000,000 419,000,000 369,000,000 -285,000,000 -190,000,000 744,000,000 416,000 93,000,000  
      other financing activities
    		0 -14,000,000 6,000,000 -6,000,000 -1,000,000 -22,000,000 1,000,000 -2,000,000 -5,000,000 -7,000,000 -6,000,000 -5,000,000 -14,000,000 -10,000,000 3,000,000 -6,000,000 -10,000,000 -8,000,000 -7,000,000 -9,000,000 -9,000,000 -9,000,000 -16,000,000  -30,000,000 -5,000 
      net cash from financing activities
    		306,000,000 271,000,000 119,000,000 161,000,000 -93,000,000 248,000,000 562,000,000 -136,000,000 302,000,000 603,000,000 -974,000,000 -2,814,000,000 -3,531,000,000 -71,000,000 -712,000,000 165,000,000 56,000,000 142,000,000 364,000,000 331,000,000 27,000,000 104,000,000 607,000,000   -409,000 
      net decrease in cash, cash equivalents and restricted cash
    		    3,000,000 -61,000,000  27,000,000                   
      cash, cash equivalents and restricted cash at beginning of period
    		0 339,000,000 0 0 0 382,000,000 0 0 0 3,572,000,000 0 0 0 443,000,000 0 0 0 643,000,000 0 511,000,000       
      cash, cash equivalents and restricted cash at end of period
    		-22,000,000 340,000,000 -244,000,000 259,000,000 3,000,000 321,000,000 28,000,000 27,000,000 53,000,000 4,250,000,000 -1,196,000,000 -2,862,000,000 7,208,000,000 422,000,000 -532,000,000 262,000,000 -112,000,000 540,000,000 222,000,000 653,000,000       
      supplemental disclosures of cash flow information
    		                          
      significant non-cash transactions:
    		                          
      accrued expenditures for property, plant and equipment at june 30,
    		                          
      net increase in cash, cash equivalents and restricted cash
    		 1,000,000 -244,000,000      53,000,000 678,000,000 -1,196,000,000 -2,862,000,000 7,208,000,000 -21,000,000 -532,000,000 262,000,000 -112,000,000 -103,000,000 222,000,000 142,000,000       
      accrued expenditures for property, plant and equipment at march 31,
    		 397,000,000    253,000,000    236,000,000    229,000,000    322,000,000  313,000,000   236,000,000    
      income from discontinued operations
    		                          
      income from continuing operations
    		         273,000,000 142,000,000 209,000,000 -536,000,000 203,000,000             
      defined benefit plans - expense
    		                    -24,000,000 -26,000,000 -19,000,000   21,000 
      stock compensation expense
    		                          
      loss on sale of safari holdings
    		                          
      proceeds from transfer of excess benefit plan funds
    		                          
      proceeds from sale of safari holdings, net of cash divested
    		                          
      acquisition of narragansett electric, net of cash acquired
    		        14,000,000                  
      retirement of long-term debt
    		      -91,000,000 0 -1,000,000  0 -2,227,000,000    0     0     0 
      cash paid (received) during the period for:
    		                          
      interest - net of amount capitalized
    		                          
      income taxes - net
    		                          
      accrued expenditures for property, plant and equipment at december 31,
    		                          
      net decrease in short-term debt
    		   -389,000,000                      -285,000 
      accrued expenditures for property, plant and equipment at september 30,
    		                          
      loss
    		          8,000,000 2,000,000 -555,000,000 2,043,000,000             
      impairment of solar panels
    		          0 0               
      loss on extinguishment of debt
    		          0 73,000,000               
      net cash from operating activities - continuing operations
    		        219,000,000 502,000,000 292,000,000 457,000,000 399,000,000 396,000,000             
      net cash from operating activities - discontinued operations
    		          0 0 459,000,000 267,000,000             
      proceeds from sale of u.k. utility business, net of cash divested
    		                          
      net cash from investing activities - continuing operations
    		        -468,000,000 -427,000,000 -514,000,000 -505,000,000 10,055,000,000 -472,000,000             
      net cash from investing activities - discontinued operations
    		          0 0 -344,000,000 -263,000,000             
      purchase of treasury stock
    		          -721,000,000                
      retirement of term loan
    		          0 0 0 -300,000,000             
      retirement of commercial paper
    		          0 0 0 -73,000,000             
      net cash from financing activities - continuing operations
    		        302,000,000 603,000,000 -974,000,000 -2,814,000,000 -3,611,000,000 55,000,000             
      net cash from financing activities - discontinued operations
    		          0 0 -285,000,000 -126,000,000             
      contributions from discontinued operations
    		                          
      effect of exchange rates on cash, cash equivalents and restricted cash included in discontinued operations
    		          0 0 0 8,000,000             
      net increase in cash, cash equivalents and restricted cash included in discontinued operations
    		          0 0 170,000,000 114,000,000             
      cash paid during the period for:
    		                          
      stock-based compensation expense
    		         11,000,000    6,000,000 5,000,000 5,000,000 5,000,000 14,000,000 1,000,000 15,000,000 8,000,000 3,000,000 19,000,000    
      impairment of assets held for sale
    		                          
      issuance of term loan
    		              0            
      issuance of commercial paper
    		                          
      income
    		                          
      proceeds from sale of discontinued operations, net of cash divested
    		          0 0               
      net decrease in cash, cash equivalents and restricted cash included in discontinued operations
    		                          
      issuance of common stock
    		          4,000,000   1,000,000 -1,000,000 14,000,000 13,000,000 22,000,000 47,000,000 100,000,000 98,000,000 104,000,000 73,000,000 20,000 16,000,000  
      proceeds from project financing
    		          -2,000,000 16,000,000 0 5,000,000 56,000,000            
      contributions (to) from discontinued operations
    		           0               
      unrealized (gains) losses on derivatives, and other hedging activities
    		              73,000,000      59,000,000 100,000,000 35,000,000    
      other current liabilities
    		             -103,000,000 8,000,000 -9,000,000 -13,000,000 -72,000,000 73,000,000 -120,000,000 -1,000,000 8,000,000 -60,000,000    
      purchase of investments
    		               0 0 -55,000,000         
      proceeds from the sale of investments
    		              -7,000,000 2,000,000 4,000,000 57,000,000         
      effect of exchange rates on cash, cash equivalents and restricted cash
    		              17,000,000 -6,000,000 -7,000,000 3,000,000 -5,000,000 -2,000,000       
      accrued expenditures for intangible assets at september 30,
    		                          
      accrued expenditures for intangible assets at june 30,
    		                          
      unrealized gains on derivatives, and other hedging activities
    		                          
      defined benefit plans -
    		                -69,000,000 -66,000,000 -51,000,000 -50,000,000       
      unrealized losses on derivatives, and other hedging activities
    		                 53,000,000  85,000,000      251,000 
      accrued expenditures for intangible assets at march 31,
    		                 64,000,000  65,000,000   62,000,000    
      purchase of available-for-sale securities
    		                          
      expenditures for intangible assets
    		                   -7,000,000 -10,000,000 -12,000,000 -3,000,000   -22,000 
      settlement of cross-currency swaps
    		                          
      effect of exchange rates on cash and cash equivalents
    		                    0 4,000,000 3,000,000 -14,000 8,000,000 15,000 
      net increase in cash and cash equivalents
    		                    209,000,000 58,000,000 68,000,000 -48,000 -99,000,000 348,000 
      cash and cash equivalents at beginning of period
    		                    0 0 341,000,000 901,000 1,202,000,000 0 
      cash and cash equivalents at end of period
    		                    209,000,000 58,000,000 409,000,000 853,000 1,103,000,000 348,000 
      counterparty collateral
    		                         71,000 
      net increase in restricted cash and cash equivalents
    		                      2,000,000 -52,000 -22,000,000  
      proceeds from the receipt of grants
    		                          
      repurchase of common stock
    		                          
      debt issuance and credit facility costs
    		                       -18,000   
      contract adjustment payments
    		                       -24,000   
      proceeds from the sale of other investments
    		                        16,000,000  
      the accompanying notes to condensed financial statements are an integral part of the financial statements.
    		                          
      proceeds from the sale of certain non-core generation facilities
    		                          
      ironwood acquisition, net of cash acquired
    		                          
      acquisition of wpd midlands
    		                          
      redemption of preference stock of a subsidiary
    		                          
      gains related to the extinguishment of notes
    		                          
      impairment of assets
    		                         104,000 
      benefit from montana hydroelectric litigation
    		                         3,000 
      unbilled revenue
    		                         151,000 
      price risk management assets and liabilities
    		                         -14,000 
      proceeds from the sale of the long island generation business
    		                         0 
      purchases of nuclear plant decommissioning trust investments
    		                         -18,000 
      proceeds from the sale of nuclear plant decommissioning trust investments
    		                         15,000 
      net decrease in restricted cash and cash equivalents
    		                         -2,000 
      issuance of equity, net of issuance costs
    		                         15,000 
      redemption of preferred stock of a subsidiary
    		                         0 
      debt issuance costs
    		                         -3,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.